, and problem-solve. We are currently hiring a ClinicalResearchAssociate II or Sr. CRA to join our thriving team in Poland... take healthcare and clinicalresearch personally, with shared experiences that drive a passion to heal, cure and solve...
Poland. Notre entreprise: IDEAL PROFILE Education B.Sc. in a related field of study to clinicalresearch M.Sc. or Ph...Senior Projects Managers are crucial to the success of Clinical Trials managed by Innovaderm. They are the main point...
Updated: Yesterday Location: Europe-Poland, Poland Job ID: 24002760 Description Senior ClinicalResearch... Associate I Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer...
of regulatory source documents for the clinical regulatory intelligence. Support ad-hoc research requests from the business... Regulatory Intelligence Associate Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built...
A Senior ClinicalResearchAssociate (Senior Site Manager) serves as the primary contact point between the Sponsor... and the Investigational Site. A Senior ClinicalResearchAssociate is assigned to trial sites to ensure inspection readiness...
Updated: Yesterday Location: Europe-Poland, Poland Job ID: 24002669 Description Senior ClinicalResearch... Associate I Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer...
A Senior ClinicalResearchAssociate (Senior Site Manager) serves as the primary contact point between the Sponsor... and the Investigational Site. A Senior ClinicalResearchAssociate is assigned to trial sites to ensure inspection readiness...
team of ClinicalResearch Associates Use new technology and smart monitoring tools Have flexibility of work and good... research study, taking overall responsibility of allocated sites and actively develop and expand the territory for clinical...
Updated: Yesterday Location: Europe-Poland, Poland Job ID: 24002541 Description Senior ClinicalResearch... Associate I Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer...
take healthcare and clinicalresearch personally, with shared experiences that drive a passion to heal, cure and solve..., and problem-solve. As a Clinical Data Associate / Clinical Data Manager I at Rho, you will have the opportunity to collect...
Manpansand Beverages' top officials have been asked to pay penalties totaling ₹74 lakh by SEBI for violations including misstating and manipulating financial statements. Continue Reading »
Stock Market Today- Cipla, Aurobindo, Torrent are 3 preferred picks of HSBC Research on healthy Q4 expectations. HSBC expects 38.4% y-o-y rise in net profit of pharma companies in their coverage during Q4 helped by rising US sales compensating for slower growth in India Continue Reading »
SK Finance's proposed IPO is a combination of a fresh issue of equity shares worth ₹500 crore and an OFS of up to ₹1,700 crore by promoters and investor shareholders Continue Reading »
Emudhra, a leading certifying authority in India, has seen its stock value surge by 245% in the past year, reaching ₹738.40. Centrum Broking in its recent note revised its price target price on the stock to ₹832 apiece. Reflecting on a strong spike in the share price, it adjusted its rating. Continue Reading »
Post FY24 results, most brokerage houses have kept their target price for Tata Chemicals at least 10% lower than the current market price Continue Reading »
With the 2024 general elections in India ongoing, investors are preparing for market volatility as Prime Minister Narendra Modi seeks a third term. Analysts suggest different strategies, from increasing equity exposure to adding gold and long-tenure debt to portfolios. Continue Reading »
Top Gainers and Losers Today : The Sensex gained 128.33 points, or 0.17, to settle at 74482.78, while the Nifty gained 43.35 points, or 0.19, to close at 22604.85. Continue Reading »
The marketing segment failed to compensate for the weak showing by the refining business, leading to muted Q4 results. And according to analysts at Kotak Institutional Equities, oil marketing companies are in for a dismal Q1FY25. Continue Reading »